| [1] |
汪徐林,邵建国,朱永昌, 等. 江苏省南通地区2005年至2014年慢加急性肝功能衰竭流行病学调查分析[J]. 中华传染病杂志,2016,34(9):530-535.
|
| [2] |
McMahon BJ,Alward WL,Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state[J]. J Infect Dis,1985,151(4):599-603.
|
| [3] |
Zou H,Chen Y,Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers[J]. J Viral Hepat,2012,19(2):e18-e25.
|
| [4] |
Wong VC,Ip HM,Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study[J]. Lancet,1984,1(8383):921-926.
|
| [5] |
Lo KJ,Tsai YT,Lee SD, et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan[J]. Hepatogastroenterology,1985,32(2):65-68.
|
| [6] |
Xu ZY,Duan SC,Margolis HS, et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People’s Republic of China Study Group on Hepatitis B[J]. J Infect Dis,1995,171(1):54-60.
|
| [7] |
Farmer K,Gunn T,Woodfield DG. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers[J]. N Z Med J,1987,100(827):412-414.
|
| [8] |
Theppisai U,Thanuntaseth C,Chiewsilp P, et al. A comparison between the efficacy of passive-active and active immunization for prevention of perinatal transmission of hepatitis B virus[J]. J Med Assoc Thai,1987,70(8):459-462.
|
| [9] |
Poovorawan Y,Sanpavat S,Pongpunglert W, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers[J]. Pediatr Infect Dis J,1992,11(5Pt1):816-821.
|
| [10] |
Sehgal A,Sehgal R,Gupta I, et al. Use of hepatitis B vaccine alone or in combination with hepatitis B immunoglobulin for immunoprophylaxis of perinatal hepatitis B infection[J]. J Trop Pediatr,1992,38(5):247-251.
|
| [11] |
Assateerawatt A,Tanphaichitr VS,Suvatte V, et al. Immunogenicity and efficacy of a recombinant DNA hepatitis B vaccine, GenHevac B Pasteur in high risk neonates, school children and healthy adults[J]. Asian Pac J Allergy Immunol,1993,11(1):85-91.
|
| [12] |
Pande C,Sarin SK,Patra S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial[J]. J Viral Hepat, 2013,20(11):801-810.
|
| [13] |
Zhu Q,Yu G,Yu H, et al. A randomized control trial on interruption of HBV transmission in uterus[J]. Chin Med J (Engl),2003,116(5):685-687.
|
| [14] |
Yuan J,Lin J,Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study[J]. J Viral Hepat,2006,13(9):597-604.
|
| [15] |
王福彦,林平,张慧珠. 预防乙型肝炎病毒母婴传播的随机对照研究[J]. 中华儿科杂志,2008,46(1):61-63.
|
| [16] |
Xu WM,Cui YT,Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study[J]. J Viral Hepat,2009,16(2):94-103.
|
| [17] |
张丽菊,王玲. 替比夫定对妊娠后期乙型肝炎病毒宫内感染的阻断作用[J]. 中华肝脏病杂志,2009,17(8):561-563.
|
| [18] |
Pan CQ,Duan Z,Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J]. N Engl J Med,2016,374(24):2324-2334.
|
| [19] |
Brown RS Jr,McMahon BJ,Lok AS, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis[J]. Hepatology,2016,63(1):319-333.
|
| [20] |
Zhou YH. Prevention of mother-to-child transmission of hepatitis B virus by treating mothers with high viral loads[J]. Hepatology, 2016,64(5):1823-1824.
|
| [21] |
Visvanathan K,Dusheiko G,Giles M, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders[J]. Gut,2016,65(2):340-350.
|
| [22] |
Anh NT. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study[J]. Lancet Gastroenterol Hepatol,2018,3(6):383-403.
|
| [23] |
Shi Z,Li X,Ma L, et al. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis[J]. Int J Infect Dis,2010,14(7):e622-e634.
|
| [24] |
Chen ZX,Gu GF,Bian ZL, et al. Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: a real-world prospective cohort study[J]. J Infect,2017,75(2):146-154.
|
| [25] |
Govan L,Wu O,Xin Y, et al. Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis[J]. Eur J Gastroenterol Hepatol,2015,27(8):882-894.
|
| [26] |
Pan CQ,Zou HB,Chen Y, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants[J]. Clin Gastroenterol Hepatol,2013,11(10):1349-1355.
|
| [27] |
Hu Y,Dai X,Zhou YH, et al. A knowledge survey of obstetrics and gynecology staff on the prevention of mother-to-child transmission of hepatitis B virus[J]. J Infect Dev Ctries,2013,7(5):391-397.
|
| [28] |
Buchanan C,Tran TT. Management of chronic hepatitis B in pregnancy[J]. Clin Liver Dis,2010,14(3):495-504.
|